United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $792,942,001.75
- Dec. 18, 2024
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 18, 2024 | Director | 26,209 | $373.22 | Sell | $9,781,722.98 | |
| Dec. 5, 2024 | EVP | 7,700 | $374.37 | Sell | $2,882,649.00 | |
| Nov. 25, 2024 | COO | 10,000 | $372.75 | Sell | $3,727,500.00 | |
| Nov. 21, 2024 | EVP | 7,700 | $367.36 | Sell | $2,828,672.00 | |
| Nov. 11, 2024 | COO | 15,000 | $407.32 | Sell | $6,109,800.00 | |
| Nov. 11, 2024 | Director | 1,750 | $412.48 | Sell | $721,840.00 | |
| Nov. 8, 2024 | Director | 224 | $412.28 | Sell | $92,350.72 | |
| Nov. 7, 2024 | COO | 15,000 | $401.44 | Sell | $6,021,600.00 | |
| Nov. 1, 2024 | Director | 510 | $376.63 | Sell | $192,081.30 | |
| Nov. 1, 2024 | COO | 14,700 | $374.46 | Sell | $5,504,562.00 | |
| Oct. 28, 2024 | CFO | 7,800 | $350.00 | Sell | $2,730,000.00 | |
| Oct. 21, 2024 | CFO | 7,782 | $366.99 | Sell | $2,855,916.18 | |
| Oct. 14, 2024 | CFO | 7,792 | $355.88 | Sell | $2,773,016.96 | |
| Oct. 7, 2024 | CFO | 7,794 | $355.54 | Sell | $2,771,078.76 | |
| Sept. 30, 2024 | CFO | 7,792 | $358.62 | Sell | $2,794,367.04 | |
| Sept. 23, 2024 | CFO | 7,796 | $354.04 | Sell | $2,760,095.84 | |
| Sept. 9, 2024 | CFO | 7,802 | $345.41 | Sell | $2,694,888.82 | |
| Sept. 3, 2024 | CFO | 7,785 | $362.37 | Sell | $2,821,050.45 | |
| Aug. 26, 2024 | CEO | 269 | $348.41 | Sell | $93,722.29 | |
| Aug. 19, 2024 | CEO | 3,600 | $344.18 | Sell | $1,239,048.00 | |
| Aug. 8, 2024 | CEO | 3,600 | $328.39 | Sell | $1,182,204.00 | |
| Aug. 7, 2024 | COO | 25,000 | $323.38 | Sell | $8,084,500.00 | |
| Aug. 6, 2024 | CEO | 3,600 | $325.45 | Sell | $1,171,620.00 | |
| Aug. 2, 2024 | CEO | 3,600 | $324.73 | Sell | $1,169,028.00 | |
| Aug. 2, 2024 | Director | 5,000 | $325.35 | Sell | $1,626,750.00 | |
| July 30, 2024 | CEO | 3,600 | $337.40 | Sell | $1,214,640.00 | |
| July 26, 2024 | CEO | 3,600 | $338.61 | Sell | $1,218,996.00 | |
| July 24, 2024 | CEO | 3,600 | $334.00 | Sell | $1,202,400.00 | |
| July 22, 2024 | CEO | 3,600 | $331.32 | Sell | $1,192,752.00 | |
| July 18, 2024 | CEO | 3,600 | $331.79 | Sell | $1,194,444.00 | |
| July 16, 2024 | CEO | 3,600 | $328.03 | Sell | $1,180,908.00 | |
| July 12, 2024 | CEO | 3,600 | $324.97 | Sell | $1,169,892.00 | |
| July 10, 2024 | CEO | 3,600 | $326.35 | Sell | $1,174,860.00 | |
| July 8, 2024 | CEO | 3,600 | $317.05 | Sell | $1,141,380.00 | |
| July 5, 2024 | CEO | 3,600 | $313.25 | Sell | $1,127,700.00 | |
| July 3, 2024 | CEO | 3,600 | $312.48 | Sell | $1,124,928.00 | |
| July 1, 2024 | CEO | 3,600 | $320.45 | Sell | $1,153,620.00 | |
| June 27, 2024 | CEO | 3,600 | $316.62 | Sell | $1,139,832.00 | |
| June 25, 2024 | Director | 266 | $318.58 | Sell | $84,742.28 | |
| June 24, 2024 | CEO | 3,600 | $315.97 | Sell | $1,137,492.00 | |
| June 21, 2024 | CEO | 3,600 | $313.91 | Sell | $1,130,076.00 | |
| June 14, 2024 | CEO | 3,600 | $287.22 | Sell | $1,033,992.00 | |
| June 13, 2024 | Director | 2,000 | $281.53 | Sell | $563,060.00 | |
| June 12, 2024 | CEO | 3,600 | $281.19 | Sell | $1,012,284.00 | |
| June 10, 2024 | CEO | 3,600 | $273.95 | Sell | $986,220.00 | |
| June 7, 2024 | CEO | 3,600 | $277.13 | Sell | $997,668.00 | |
| May 31, 2024 | CEO | 3,600 | $272.48 | Sell | $980,928.00 | |
| May 28, 2024 | Director | 3,600 | $269.06 | Sell | $968,616.00 | |
| May 23, 2024 | Director | 3,600 | $275.78 | Sell | $992,808.00 | |
| May 21, 2024 | Director | 1,468 | $275.85 | Sell | $404,947.80 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Paul A. Mahon, Ray Kurzweil, DWEK RAYMOND, MAHON PAUL A, Louis Sullivan, R Paul Gray, Judy D. Olian, and Tommy G. Thompson
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Dec. 18, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.